These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 33909604)

  • 21. Beyond low-density lipoprotein: addressing the atherogenic lipid triad in type 2 diabetes mellitus and the metabolic syndrome.
    Nesto RW
    Am J Cardiovasc Drugs; 2005; 5(6):379-87. PubMed ID: 16259526
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DOCK7-ANGPTL3 SNPs and their haplotypes with serum lipid levels and the risk of coronary artery disease and ischemic stroke.
    Li WJ; Yin RX; Cao XL; Chen WX; Huang F; Wu JZ
    Lipids Health Dis; 2018 Feb; 17(1):30. PubMed ID: 29454388
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulation of angiopoietin-like protein 8 expression under different nutritional and metabolic status.
    Guo C; Zhao Z; Deng X; Chen Z; Tu Z; Yuan G
    Endocr J; 2019 Dec; 66(12):1039-1046. PubMed ID: 31631098
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Coding Variation in ANGPTL4, LPL, and SVEP1 and the Risk of Coronary Disease.
    ; Stitziel NO; Stirrups KE; Masca NG; Erdmann J; Ferrario PG; König IR; Weeke PE; Webb TR; Auer PL; Schick UM; Lu Y; Zhang H; Dube MP; Goel A; Farrall M; Peloso GM; Won HH; Do R; van Iperen E; Kanoni S; Kruppa J; Mahajan A; Scott RA; Willenberg C; Braund PS; van Capelleveen JC; Doney AS; Donnelly LA; Asselta R; Merlini PA; Duga S; Marziliano N; Denny JC; Shaffer CM; El-Mokhtari NE; Franke A; Gottesman O; Heilmann S; Hengstenberg C; Hoffman P; Holmen OL; Hveem K; Jansson JH; Jöckel KH; Kessler T; Kriebel J; Laugwitz KL; Marouli E; Martinelli N; McCarthy MI; Van Zuydam NR; Meisinger C; Esko T; Mihailov E; Escher SA; Alver M; Moebus S; Morris AD; Müller-Nurasyid M; Nikpay M; Olivieri O; Lemieux Perreault LP; AlQarawi A; Robertson NR; Akinsanya KO; Reilly DF; Vogt TF; Yin W; Asselbergs FW; Kooperberg C; Jackson RD; Stahl E; Strauch K; Varga TV; Waldenberger M; Zeng L; Kraja AT; Liu C; Ehret GB; Newton-Cheh C; Chasman DI; Chowdhury R; Ferrario M; Ford I; Jukema JW; Kee F; Kuulasmaa K; Nordestgaard BG; Perola M; Saleheen D; Sattar N; Surendran P; Tregouet D; Young R; Howson JM; Butterworth AS; Danesh J; Ardissino D; Bottinger EP; Erbel R; Franks PW; Girelli D; Hall AS; Hovingh GK; Kastrati A; Lieb W; Meitinger T; Kraus WE; Shah SH; McPherson R; Orho-Melander M; Melander O; Metspalu A; Palmer CN; Peters A; Rader D; Reilly MP; Loos RJ; Reiner AP; Roden DM; Tardif JC; Thompson JR; Wareham NJ; Watkins H; Willer CJ; Kathiresan S; Deloukas P; Samani NJ; Schunkert H
    N Engl J Med; 2016 Mar; 374(12):1134-44. PubMed ID: 26934567
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased ANGPTL3, 4 and ANGPTL8/betatrophin expression levels in obesity and T2D.
    Abu-Farha M; Al-Khairi I; Cherian P; Chandy B; Sriraman D; Alhubail A; Al-Refaei F; AlTerki A; Abubaker J
    Lipids Health Dis; 2016 Oct; 15(1):181. PubMed ID: 27733177
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ANGPTL4 variants E40K and T266M are associated with lower fasting triglyceride levels and predicts cardiovascular disease risk in Type 2 diabetic Tunisian population.
    Abid K; Trimeche T; Mili D; Msolli MA; Trabelsi I; Nouira S; Kenani A
    Lipids Health Dis; 2016 Mar; 15():63. PubMed ID: 27004807
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New insights into ANGPTL8 in modulating the development of cardio-metabolic disorder diseases.
    Su X; Zhang G; Cheng Y; Wang B
    Mol Biol Rep; 2021 Apr; 48(4):3761-3771. PubMed ID: 33864591
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pleiotropy-Based Decomposition of Genetic Risk Scores: Association and Interaction Analysis for Type 2 Diabetes and CAD.
    Chasman DI; Giulianini F; Demler OV; Udler MS
    Am J Hum Genet; 2020 May; 106(5):646-658. PubMed ID: 32302534
    [TBL] [Abstract][Full Text] [Related]  

  • 29.
    Cannon ME; Duan Q; Wu Y; Zeynalzadeh M; Xu Z; Kangas AJ; Soininen P; Ala-Korpela M; Civelek M; Lusis AJ; Kuusisto J; Collins FS; Boehnke M; Tang H; Laakso M; Li Y; Mohlke KL
    G3 (Bethesda); 2017 Sep; 7(9):3217-3227. PubMed ID: 28754724
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetics of type 2 diabetes and coronary artery disease and their associations with twelve cardiometabolic traits in the United Arab Emirates population.
    Osman W; Hassoun A; Jelinek HF; Almahmeed W; Afandi B; Tay GK; Alsafar H
    Gene; 2020 Aug; 750():144722. PubMed ID: 32360841
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dyslipidemia in type 2 diabetes mellitus.
    Gadi R; Samaha FF
    Curr Diab Rep; 2007 Jun; 7(3):228-34. PubMed ID: 17547840
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Triglyceride-Rich Lipoprotein Cholesterol and Risk of Cardiovascular Events Among Patients Receiving Statin Therapy in the TNT Trial.
    Vallejo-Vaz AJ; Fayyad R; Boekholdt SM; Hovingh GK; Kastelein JJ; Melamed S; Barter P; Waters DD; Ray KK
    Circulation; 2018 Aug; 138(8):770-781. PubMed ID: 29618599
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlation between miR-103 and miR-133a Expression and the Circulating ANGPTL8 in Type 2 Diabetic Patients and Healthy Control Subjects.
    Ghasemi H; Karimi J; Khodadadi I; Tavilani H
    Clin Lab; 2019 Nov; 65(11):. PubMed ID: 31710446
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ANGPTL8 in cardio-metabolic diseases.
    Su X; Cheng Y; Wang B
    Clin Chim Acta; 2021 Aug; 519():260-266. PubMed ID: 34023284
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Visualizing the regulatory role of Angiopoietin-like protein 8 (ANGPTL8) in glucose and lipid metabolic pathways.
    Siddiqa A; Cirillo E; Tareen SHK; Ali A; Kutmon M; Eijssen LMT; Ahmad J; Evelo CT; Coort SL
    Genomics; 2017 Oct; 109(5-6):408-418. PubMed ID: 28684091
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of KALRN, ADIPOQ, and FTO gene polymorphism in type 2 diabetic patients with coronary artery disease: possible predisposing markers.
    Mofarrah M; Ziaee S; Pilehvar-Soltanahmadi Y; Zarghami F; Boroumand M; Zarghami N
    Coron Artery Dis; 2016 Sep; 27(6):490-6. PubMed ID: 27218147
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Polymorphisms in FADS1 and FADS2 alter plasma fatty acids and desaturase levels in type 2 diabetic patients with coronary artery disease.
    Li SW; Wang J; Yang Y; Liu ZJ; Cheng L; Liu HY; Ma P; Luo W; Liu SM
    J Transl Med; 2016 Mar; 14():79. PubMed ID: 27004414
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic implications of statin intolerance in stable coronary artery disease patients with different levels of high-sensitive troponin.
    Hai JJ; Wong YK; Wong CK; Un KC; Chan PH; Siu CW; Yiu KH; Lau CP; Tse HF
    BMC Cardiovasc Disord; 2019 Jul; 19(1):168. PubMed ID: 31307391
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Proinflammatory Role of ANGPTL8 R59W Variant in Modulating Inflammation through NF-κB Signaling Pathway under TNFα Stimulation.
    Abu-Farha M; Madhu D; Hebbar P; Mohammad A; Channanath A; Kavalakatt S; Alam-Eldin N; Alterki F; Taher I; Alsmadi O; Shehab M; Arefanian H; Ahmad R; Thanaraj TA; Al-Mulla F; Abubaker J
    Cells; 2023 Nov; 12(21):. PubMed ID: 37947641
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Clinical Role of Angiopoietin-Like Protein 3 in Evaluating Coronary Artery Disease in Patients with Obstructive Sleep Apnea.
    Li J; Yang Y; Jiao X; Yu H; Du Y; Zhang M; Hu C; Wei Y; Qin Y
    Cardiovasc Drugs Ther; 2020 Dec; 34(6):773-780. PubMed ID: 32440963
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.